Anthem Bioscienc

Part of MojoOne Strategy

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0CZ201020
NSEID: ANTHEM
BSEID: 544449
View on NSE | View on BSE

INR

773.15

3.45 (0.45%)

BSENSE

Jul 06, 02:22 PM

BSE+NSE Vol: 1.6 lacs

Access older stock analysis version

{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "773.15",
    "chg": 3.45,
    "chgp": "0.45%",
    "dir": 1,
    "prev_price": "769.70",
    "mcapval": "43,543.43 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0CZ201020",
    "curr_date": "Jul 06, 02:22 PM",
    "curr_time": "14:23 PM",
    "last_traded_at": "Jul 06, 02:22 PM IST",
    "bse_nse_vol": "1.6 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 06, 2026",
    "traded_date_str": "2026 07 06",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-buy-4089543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_mojoScore_4089543.png",
        "date": "2026-07-05 10:10:05",
        "description": "Anthem Biosciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 05 July 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4084123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_technicaldot_4084123.png",
        "date": "2026-07-02 08:10:43",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early July 2026. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4078096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnthemBioscienc_technicaldot_4078096.png",
        "date": "2026-06-30 08:09:50",
        "description": "Anthem Biosciences Ltd has demonstrated a marked improvement in price momentum, shifting from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages. This technical resurgence coincides with a significant upgrade in its Mojo Grade from Sell to Buy, reflecting growing investor confidence in the mid-cap pharmaceutical and biotechnology firm."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4076477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnthemBioscienc_technicaldot_4076477.png",
        "date": "2026-06-29 08:03:56",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a slight dip in daily price, the stock’s technical indicators present a nuanced picture, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-buy-4070411",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnthemBioscienc_mojoScore_4070411.png",
        "date": "2026-06-24 10:10:04",
        "description": "Anthem Biosciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-buy-by-marketsmojo-4051097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnthemBioscienc_mojoScore_4051097.png",
        "date": "2026-06-13 10:10:05",
        "description": "Anthem Biosciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-buy-4030712",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnthemBioscienc_mojoScore_4030712.png",
        "date": "2026-06-02 10:10:03",
        "description": "Anthem Biosciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 June 2026, providing investors with the latest insights into its fundamentals, returns, and overall market stance."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4029969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnthemBioscienc_technicaldot_4029969.png",
        "date": "2026-06-02 08:11:54",
        "description": "Anthem Biosciences Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. This change, coupled with an upgrade in its Mojo Grade from Sell to Buy, reflects improving market sentiment and potential upside for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Anthem Biosciences Ltd’s Mixed Week: -0.89% Price Change Amid Technical Shifts and Quality Upgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltds-mixed-week--089-price-change-amid-technical-shifts-and-quality-upgrade-4007658",
        "imagepath": "",
        "date": "2026-05-23 09:04:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens at ₹789.95, up 0.82% despite Sensex decline</p>\n                    <p><strong>19 May:</strong> Downgrade to Sell announced amid technical weakness and financial setbacks</p>\n                    <p><strong>20 May:</strong> Formation of Golden Cross signals potential bullish breakout</p>\n                    <p><strong>21 May:</strong> Technical momentum shifts to mildly bullish despite price decline</p>\n                    <p><strong>22 May:</strong> Quality grade upgraded to Excellent; rating upgraded to Buy</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</..."
      }
    ],
    "total": 55,
    "sid": "10039665",
    "stock_news_url": "https://www.marketsmojo.com/news/anthem-biosciences-10039665"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "03-Jul-2026",
      "details": "Intimation of Revision in Credit Rating",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR)- Newspaper Publication",
      "datetime": "01-Jul-2026",
      "details": "Newspaper advertisement regarding the completion of dispatch of notice of the 20th Annual General Meeting of the Company",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "30-Jun-2026",
      "details": "Annual Report for the FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anthem Biosciences Ltd has declared <strong>100%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anthem Biosciences Ltd is Rated Buy

2026-07-05 10:10:05

Anthem Biosciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 05 July 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-07-02 08:10:43

Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early July 2026. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the pharmaceuticals and biotechnology sector.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-30 08:09:50

Anthem Biosciences Ltd has demonstrated a marked improvement in price momentum, shifting from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages. This technical resurgence coincides with a significant upgrade in its Mojo Grade from Sell to Buy, reflecting growing investor confidence in the mid-cap pharmaceutical and biotechnology firm.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-06-29 08:03:56

Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a slight dip in daily price, the stock’s technical indicators present a nuanced picture, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector.

Read full news article

Anthem Biosciences Ltd is Rated Buy

2026-06-24 10:10:04

Anthem Biosciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Anthem Biosciences Ltd is Rated Buy by MarketsMOJO

2026-06-13 10:10:05

Anthem Biosciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anthem Biosciences Ltd is Rated Buy

2026-06-02 10:10:03

Anthem Biosciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 June 2026, providing investors with the latest insights into its fundamentals, returns, and overall market stance.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-02 08:11:54

Anthem Biosciences Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. This change, coupled with an upgrade in its Mojo Grade from Sell to Buy, reflects improving market sentiment and potential upside for investors in the Pharmaceuticals & Biotechnology sector.